Correlation Between Sana Biotechnology and Transcode Therapeutics
Can any of the company-specific risk be diversified away by investing in both Sana Biotechnology and Transcode Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sana Biotechnology and Transcode Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sana Biotechnology and Transcode Therapeutics, you can compare the effects of market volatilities on Sana Biotechnology and Transcode Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sana Biotechnology with a short position of Transcode Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sana Biotechnology and Transcode Therapeutics.
Diversification Opportunities for Sana Biotechnology and Transcode Therapeutics
0.86 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Sana and Transcode is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding Sana Biotechnology and Transcode Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Transcode Therapeutics and Sana Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sana Biotechnology are associated (or correlated) with Transcode Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Transcode Therapeutics has no effect on the direction of Sana Biotechnology i.e., Sana Biotechnology and Transcode Therapeutics go up and down completely randomly.
Pair Corralation between Sana Biotechnology and Transcode Therapeutics
Given the investment horizon of 90 days Sana Biotechnology is expected to generate 0.57 times more return on investment than Transcode Therapeutics. However, Sana Biotechnology is 1.76 times less risky than Transcode Therapeutics. It trades about -0.21 of its potential returns per unit of risk. Transcode Therapeutics is currently generating about -0.22 per unit of risk. If you would invest 376.00 in Sana Biotechnology on September 25, 2024 and sell it today you would lose (218.00) from holding Sana Biotechnology or give up 57.98% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Sana Biotechnology vs. Transcode Therapeutics
Performance |
Timeline |
Sana Biotechnology |
Transcode Therapeutics |
Sana Biotechnology and Transcode Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Sana Biotechnology and Transcode Therapeutics
The main advantage of trading using opposite Sana Biotechnology and Transcode Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sana Biotechnology position performs unexpectedly, Transcode Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Transcode Therapeutics will offset losses from the drop in Transcode Therapeutics' long position.Sana Biotechnology vs. Fate Therapeutics | Sana Biotechnology vs. Caribou Biosciences | Sana Biotechnology vs. Arcus Biosciences | Sana Biotechnology vs. Karyopharm Therapeutics |
Transcode Therapeutics vs. Xenetic Biosciences | Transcode Therapeutics vs. Reviva Pharmaceuticals Holdings | Transcode Therapeutics vs. Eyenovia | Transcode Therapeutics vs. Cognition Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |